Literature DB >> 31609581

Hyperthermia and Controllable Free Radical Coenhanced Synergistic Therapy in Hypoxia Enabled by Near-Infrared-II Light Irradiation.

Jun Yang1, Rui Xie2,3, Lili Feng2,4, Bin Liu4, Ruichan Lv4, Chunxia Li2, Shili Gai4, Fei He4, Piaoping Yang4, Jun Lin2.   

Abstract

Tumor cell metabolism and tumor blood vessel proliferation are distinct from normal cells. The resulting tumor microenvironment presents a characteristic of hypoxia, which greatly limits the generation of oxygen free radicals and affects the therapeutic effect of photodynamic therapy. Here, we developed an oxygen-independent free radical generated nanosystem (CuFeSe2-AIPH@BSA) with dual-peak absorption in both near-infrared (NIR) regions and utilized it for imaging-guided synergistic treatment. The special absorption provides the nanosystem with high photothermal conversion efficiency and favorably matched photoactivity in both I and II NIR biological windows. Upon NIR light irradiation, the generated heat could prompt AIPH release and decompose to produce oxygen-independent free radicals for killing cancer cells effectively. The contrastive research results show that the enhanced therapeutic efficacy of NIR-II over NIR-I is principally due to its deeper tissue penetration and higher maximum permission exposure that benefits from a longer wavelength. Hyperthermia effect and the production of toxic free radicals upon NIR-II laser illumination are extremely effective in triggering apoptosis and death of cancer cells in the tumor hypoxia microenvironment. The high biocompatibility and excellent anticancer efficiency of CuFeSe2-AIPH@BSA allow it to be an ideal oxygen-independent nanosystem for imaging-guided and NIR-II-mediated synergistic therapy via systemic administration.

Entities:  

Keywords:  CuFeSe2; free radicals; hypoxia; oxygen-independent; photothermal; second near-infrared window

Year:  2019        PMID: 31609581     DOI: 10.1021/acsnano.9b05985

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  7 in total

1.  Cascade Drug-Release Strategy for Enhanced Anticancer Therapy.

Authors:  Xu Zhang; Sheng Wang; Guohui Cheng; Peng Yu; Jin Chang; Xiaoyuan Chen
Journal:  Matter       Date:  2021-01-06

2.  Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy.

Authors:  Danyang Chen; Chuang Chen; Chunyu Huang; Tongkai Chen; Zeming Liu
Journal:  Front Chem       Date:  2020-04-07       Impact factor: 5.221

3.  NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.

Authors:  Li Zhang; Yadi Fan; Zhe Yang; Mo Yang; Chun-Yuen Wong
Journal:  J Nanobiotechnology       Date:  2021-09-06       Impact factor: 10.435

4.  Natural Killer Cell Membrane-Cloaked Virus-Mimicking Nanogenerator with NIR-Triggered Shape Reversal and •C/•OH Storm for Synergistic Thermodynamic-Chemodynamic Therapy.

Authors:  Jinyan Lin; Yang Li; Peiyuan Wang; Ming Wu; Fukai Zhu; Yun Zhang; Zhenqing Hou; Jingfeng Liu; Xiaolong Liu
Journal:  Adv Sci (Weinh)       Date:  2021-12-19       Impact factor: 16.806

5.  Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy.

Authors:  Shipeng Ning; Zeming Liu; Mingzhu Chen; Daoming Zhu; Qinqin Huang
Journal:  Nanoscale Adv       Date:  2022-08-16

6.  Enhanced Tumor Targeting and Radiotherapy by Quercetin Loaded Biomimetic Nanoparticles.

Authors:  Chunyu Huang; Tongkai Chen; Daoming Zhu; Qinqin Huang
Journal:  Front Chem       Date:  2020-03-31       Impact factor: 5.221

7.  Enhanced Near-Infrared Photocatalytic Eradication of MRSA Biofilms and Osseointegration Using Oxide Perovskite-Based P-N Heterojunction.

Authors:  Congyang Mao; Weidong Zhu; Yiming Xiang; Yizhou Zhu; Jie Shen; Xiangmei Liu; Shuilin Wu; Kenneth M C Cheung; Kelvin Wai Kwok Yeung
Journal:  Adv Sci (Weinh)       Date:  2021-06-19       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.